Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedJan 24, 2025
DataAggregated Company Financials
Companies5
  • 7D1.5%
  • 3M-7.8%
  • 1Y-2.4%
  • YTD-0.1%

Over the last 7 days, the Biotech industry has risen 2.8%, driven by gains from Zealand Pharma of 6.4%. Overall in the last year, the industry is flat. As for the next few years, earnings are expected to grow by 25% per annum.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 24 Jan 2025DKK 164.8bDKK 26.0bDKK 4.7b17.1x35.1x6.3x
Sun, 22 Dec 2024DKK 160.1bDKK 26.0bDKK 4.7b16.6x34.1x6.2x
Tue, 19 Nov 2024DKK 156.0bDKK 26.0bDKK 4.7b16.4x33.2x6x
Thu, 17 Oct 2024DKK 172.2bDKK 25.5bDKK 5.5b20.7x31.5x6.8x
Sat, 14 Sep 2024DKK 199.3bDKK 25.5bDKK 5.5b23.8x36.4x7.8x
Mon, 12 Aug 2024DKK 193.4bDKK 26.0bDKK 5.7b17.9x33.9x7.4x
Wed, 10 Jul 2024DKK 194.6bDKK 24.8bDKK 5.6b17.6x34.6x7.8x
Fri, 07 Jun 2024DKK 180.1bDKK 24.8bDKK 5.6b18.6x32x7.3x
Sun, 05 May 2024DKK 184.7bDKK 25.2bDKK 6.2b16.3x30x7.3x
Tue, 02 Apr 2024DKK 190.9bDKK 23.9bDKK 5.0b19.7x38x8x
Thu, 29 Feb 2024DKK 176.9bDKK 22.8bDKK 4.3b22.9x41.4x7.8x
Sat, 27 Jan 2024DKK 167.0bDKK 23.3bDKK 4.2b22.9x40.1x7.2x
Mon, 25 Dec 2023DKK 175.3bDKK 23.3bDKK 4.2b25.7x42.1x7.5x
Wed, 22 Nov 2023DKK 171.2bDKK 23.3bDKK 4.2b24.4x41.1x7.3x
Fri, 20 Oct 2023DKK 158.5bDKK 22.0bDKK 4.7b18.3x33.5x7.2x
Sun, 17 Sep 2023DKK 203.4bDKK 22.0bDKK 4.7b23.5x43x9.2x
Tue, 15 Aug 2023DKK 192.1bDKK 20.6bDKK 3.9b37.8x49.7x9.3x
Thu, 13 Jul 2023DKK 196.9bDKK 19.5bDKK 4.4b40.4x44.7x10.1x
Sat, 10 Jun 2023DKK 206.9bDKK 19.5bDKK 4.4b43.5x47x10.6x
Mon, 08 May 2023DKK 205.8bDKK 17.9bDKK 4.1b32.3x50.3x11.5x
Wed, 05 Apr 2023DKK 195.5bDKK 17.9bDKK 3.5b30.2x55.3x10.9x
Fri, 03 Mar 2023DKK 196.8bDKK 17.3bDKK 3.1b30.3x62.7x11.3x
Sun, 29 Jan 2023DKK 203.0bDKK 14.7bDKK 3.3b30.7x62x13.8x
Tue, 27 Dec 2022DKK 222.8bDKK 14.7bDKK 3.3b34.8x68.1x15.1x
Thu, 24 Nov 2022DKK 232.1bDKK 14.7bDKK 3.3b36.3x70.9x15.8x
Sat, 22 Oct 2022DKK 202.7bDKK 12.4bDKK 1.5b44.8x133.5x16.3x
Mon, 19 Sep 2022DKK 197.5bDKK 12.4bDKK 1.5b44.1x132.7x15.9x
Wed, 17 Aug 2022DKK 205.1bDKK 12.2bDKK 1.6b43.6x129.8x16.7x
Fri, 15 Jul 2022DKK 185.3bDKK 11.1bDKK 130.5m68.7x1419.9x16.7x
Sun, 12 Jun 2022DKK 153.4bDKK 11.1bDKK 130.5m56.9x1175.9x13.9x
Tue, 10 May 2022DKK 148.6bDKK 10.7bDKK 622.4m45.5x238.8x13.9x
Thu, 07 Apr 2022DKK 184.6bDKK 10.7bDKK 625.7m55.5x295.1x17.2x
Sat, 05 Mar 2022DKK 153.9bDKK 10.4bDKK 252.9m46.3x608.4x14.8x
Mon, 31 Jan 2022DKK 159.4bDKK 9.8bDKK 117.9m48.8x1351.6x16.2x
Price to Earnings Ratio

1351.6x


Total Market Cap: DKK 159.4bTotal Earnings: DKK 117.9mTotal Revenue: DKK 9.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 134.2x202320242025
Current Industry PE
  • Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 35.2x which is lower than its 3-year average PE of 135x.
  • The 3-year average PS ratio of 11.0x is higher than the industry's current PS ratio of 6.4x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have grown 241% per year over the last three years.
  • Revenues for these companies have grown 38% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market-1.63%
Healthcare-2.62%
Biotech1.53%
Biotech1.53%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ZEAL Zealand PharmaDKK 745.006.4%
+DKK 3.2b		59.1%PS684.7x
BAVA Bavarian NordicDKK 196.750.9%
+DKK 63.1m		24.2%PE13.8x
BIOPOR BioPortoDKK 1.543.9%
+DKK 24.9m		-27.3%PS18.9x
STRAP Strategic PartnersDKK 887.407.6%
+DKK 2.6m		-26.0%PB2.3x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BIOPOR

DKK 1.54

BioPorto

7D

3.9%

1Y

-27.3%

BAVA

DKK 196.75

Bavarian Nordic

7D

0.9%

1Y

24.2%

STRAP

DKK 887.40

Strategic Partners

7D

7.6%

1Y

-26.0%

ZEAL

DKK 745.00

Zealand Pharma

7D

6.4%

1Y

59.1%

Analysts Just Made A Substantial Upgrade To Their Zealand Pharma A/S (CPH:ZEAL) Forecasts

Dec 22
Analysts Just Made A Substantial Upgrade To Their Zealand Pharma A/S (CPH:ZEAL) Forecasts

GMAB

DKK 1,512.00

Genmab

7D

-0.9%

1Y

-21.5%